PTGS2 and urothelial carcinoma: In the context of tumor recurrence associated with chemoresistance, it has been shown that elevated COX2 and secreted-PGE2 levels favor urothelial carcinoma repopulation by CK14+ cancer cells following chemotherapy-induced apoptosis [141].